Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angiotech's Quill sutures approved in Brazil

This article was originally published in Clinica

Executive Summary

Angiotech Pharmaceuticals' Quill SRS (self-retaining system) family of sutures have been approved in Brazil. The approval covers two absorbable sutures called Quill SRS polydioxanone (PDO) and Quill SRS Monoderm and two non-absorbable sutures, one made of polypropylene and one of nylon. The sutures have a patented helical barb design which eliminates the need for knots to hold them in place. The Monoderm and PDO sutures received US FDA 510(k) approval in August 2007 (see Clinica No 1270, p 18). Vancouver, Canada-based Angiotech has also launched the Quill sutures in Europe and Canada.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044095

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel